Empty Capsules Market is estimated to be valued at USD 3.65 Bn in 2026 and is expected to reach USD 5.75 Bn by 2033, growing at a compound annual growth rate (CAGR) of 6.7% from 2026 to 2033.
| Report Coverage |
Report Details |
| Base Year: |
2025 |
Market Size in 2026: |
USD 3.65 Bn |
| Historical Data for: |
2020 To 2024 |
Forecast Period: |
2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: |
6.70% |
2033 Value Projection: |
USD 5.75 Bn |
Empty capsules refer to pharmaceutical capsules that do not contain the drug substance but only serve as a vehicle for drug delivery. These are typically made from either gelatin or vegetarian materials like Hypromellose, and are available in different sizes ranging from small 000 to large capsules. Rising prevalence of various lifestyle and chronic diseases worldwide has boosted demand for pharmaceutical products and supplements. Empty capsules provide convenience and flexibility to pharmaceutical manufacturers for developing various oral solid dosage forms like capsules, tablets, and others. Developments in vegan and vegetarian capsules manufactured from natural polymers further expands the applications of empty capsules. Advancements in capsule filling technology and increasing contract manufacturing and outsourcing trend in pharmaceutical industry can drive the empty capsules market growth during the forecast period.
Market Dynamics
Global empty capsules market growth is driven by growing elderly population susceptible to various disorders, rising healthcare expenditure in emerging nations, and increasing demand for dietary supplements and nutraceuticals. However, availability of alternative drug delivery solutions and high manufacturing costs associated with empty capsules production can hamper the market growth. Developments in vegetarian empty capsules, increasing outsourcing of pharmaceutical tasks to contract service organizations, and advancements in pharmaceutical processing equipment can offer lucrative opportunities for market players. Emerging Asian markets like India and China are expected to provide attractive prospects, owing to large consumer base and improving healthcare infrastructure in these regions. Adoption of advanced capsule filling technologies like semi-automatic and automatic machines for high production capacity can offer lucrative opportunities for market growth.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global empty capsules market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Capsugel, Suheung Co Ltd., Qualicaps, ACG Worldwide, Mitsubishi Chemical Holdings, Roxlor LLC, Sunil Healthcare Limited, Patheon, and Lonza.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global empty capsules market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global empty capsules market.
Market Segmentation
- Product Insights (Revenue, USD Bn, 2021 - 2033)
- Gelatin Capsules
- Non-gelatin Capsules
- Functionality Insights (Revenue, USD Bn, 2021 - 2033)
- Immediate-release Capsules
- Delayed-release Capsules
- Sustained-release Capsules
- Material Insights (Revenue, USD Bn, 2021 - 2033)
- Pig Meat Gelatin Capsules
- Bovine Gelatin Capsules
- Plant-based Capsules
- Starch-based Capsules
- Pullulan Capsules
- Others
- End User Insights (Revenue, USD Bn, 2021 - 2033)
- Pharmaceutical Companies
- Cosmetic & Nutraceutical Companies
- Clinical Research Organizations (CRO'S)
- Others
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- ACG Worldwide
- Capsugel
- Qualicaps Inc.
- Bright Pharma Caps Inc.
- Sunil Healthcare Ltd.
- CapsCanada Corporation
- Roxlor LLC
- Snail Pharma Industry Co. Ltd.
- Suheung Co. Ltd.
- Medi-Caps Ltd.
- Qingdao Yiqing Medicinal Capsules Co., Ltd.
- Shanxi Guangsheng Medicinal Capsules Co., Ltd.
- Nectar Lifesciences Ltd.
- Kerry Inc.
- JC Biological Technology Co. Ltd.